Pimavanserin
212028
Approved small_molecule active
Quick answer
Pimavanserin for Neurodegenerative Diseases is a Approved program (small_molecule) at ACADIA PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ACADIA PHARMACEUTICALS INC
- Indication
- Neurodegenerative Diseases
- Phase
- Approved
- Modality
- small_molecule
- Status
- active